EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis

Justin K Lui iD, Fatima El-Adili, Matthew Cozzolino iD, Morgan Winburn, Marcin A Trojanowski, Deepa M Gopal, Michael P LaValley, Elizabeth S Klings, Andreea M Bujor

PLOS One · 2025

DOI: 10.1371/journal.pone.0328734 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Justin K Lui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Biomarkers, Heart Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, National Scleroderma Foundation, United Therapeutics Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We sought to investigate the relationship between serum biomarkers of cardiac dysfunction, longitudinal strain on echocardiography, and all-cause mortality in patients with systemic sclerosis.

Methods

This was an observational study using a biorepository of serum samples of patients with systemic sclerosis who underwent echocardiography. We investigated 3 biomarkers: periostin, galectin-3, and N-terminal prohormone brain natriuretic peptide and applied a K-means clustering resulting in 3 patient clusters. We subsequently measured left ventricular and right ventricular free wall longitudinal strain in each cluster. We then determined the association between each cluster and time to all-cause mortality compared to N-terminal prohormone brain natriuretic peptide, alone.

Results

The 125 patients with systemic sclerosis included in the study were divided into 3 clusters based on biomarker levels (Cluster 1: N = 75; Cluster 2: N = 39; Cluster 3: N = 11). Compared to Cluster 1, Cluster 2 had only elevated periostin levels whereas Cluster 3 had elevated levels of all 3 serum biomarkers and was characterized by reduced left ventricular and right ventricular free wall longitudinal strain, regionally and globally. When adjusted for age, sex, systemic sclerosis disease duration, and forced vital capacity, patients in Cluster 3 had a HR of 14.42 (95% CI: 4.82, 43.18) for all-cause mortality compared to those in Cluster 1.

Conclusion

In conclusion, combining N-terminal prohormone brain natriuretic peptide, periostin, and galectin-3 as serum biomarkers enhances risk stratification and sensitivity in detection of cardiac disease in patients with systemic sclerosis. However, before implementation in routine care, further prospective studies must refine biomarker sensitivity, specificity, and accuracy together with optimizing detection strategies and establishing clinical protocols for integration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicBiomarkersHeart DiseasesHumansFemaleMaleMiddle AgedNatriuretic Peptide, BrainCell Adhesion MoleculesEchocardiographyGalectin 3Peptide FragmentsAgedRisk AssessmentAdultEarly Diagnosis

Substanzen

BiomarkersNatriuretic Peptide, BrainCell Adhesion MoleculesGalectin 3Peptide FragmentsPOSTN protein, humanpro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Arthritis and Autoimmune Diseases Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Section of Rheumatology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Section of Cardiovascular Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.

ORCID-Profile: Justin K Lui, Matthew Cozzolino

Förderung

  • American Heart Association
  • National Scleroderma Foundation
  • United Therapeutics Corporation
  • School of Medicine, Boston University
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Heart, Lung, and Blood Institute
  • Boston University
  • National Center for Advancing Translational Sciences

Zitieren

APA

Lui, J. K., El-Adili, F., Cozzolino, M., Winburn, M., Trojanowski, M. A., Gopal, D. M., LaValley, M. P., Klings, E. S., & Bujor, A. M. (2025). A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis. PLOS One. https://doi.org/10.1371/journal.pone.0328734

Vancouver

Lui JK, El-Adili F, Cozzolino M, Winburn M, Trojanowski MA, Gopal DM, et al. A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis. PLOS One. 2025. doi:10.1371/journal.pone.0328734

BibTeX
@article{Lui2025,
  author = {Lui, Justin K and El-Adili, Fatima and Cozzolino, Matthew and Winburn, Morgan and Trojanowski, Marcin A and Gopal, Deepa M and LaValley, Michael P and Klings, Elizabeth S and Bujor, Andreea M},
  title = {A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328734}
}
Kostenlos starten →